Article

Are you providing great service? Ask your patients

It's easy to spot the complainer, but that is the exception.

Related Videos
Jitesh Dhingra, MD, FRCEM, answers a question during a Zoom video interview
Oliver Sartor, MD, is featured in this series.
Ravi Munver, MD, answers a question during a Zoom video interview
1 KOL is featured in this series.
1 KOL is featured in this series.
Man talking with doctor, who is taking notes on a clipboard | Image Credit: © DragonImages - stock.adobe.com
Related Content
18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer
October 15th 2024

18F rhPSMA-7.3 PET/MRI demonstrates high detection in recurrent prostate cancer

Hannah Clarke
Overall, 15/16 patients had a true positive scan based on confirmatory imaging and/or biopsy, equating to a PPV of 93.75%.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
EU approval sought for darolutamide plus ADT in mHSPC
October 15th 2024

EU approval sought for darolutamide plus ADT in mHSPC

Hannah Clarke
The application is supported by data from the pivotal phase 3 ARANOTE trial.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
Collaboration to support clinical development of PSMA-targeting theranostics in Japan
October 14th 2024

Collaboration to support clinical development of PSMA-targeting theranostics in Japan

Hannah Clarke
Both 177Lu-PSMA-I&T and 64Cu-PSMA-I&T are currently in phase 3 development for use in prostate cancer diagnostics and treatment.
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
October 14th 2024

Lisa F. Newcomb, PhD, on active surveillance for prostate cancer

Lisa F. Newcomb, PhD
"My hope is that the results of our study improve the uptake of active surveillance, further reducing unnecessary treatments, and this, combined with the improving reflex tests, may change the risk-benefit of PSA screening," says Lisa F. Newcomb, PhD.
© 2024 MJH Life Sciences

All rights reserved.